Anaqua, Inc., today announced that Ceva Santé Animale, one of the world’s fastest-growing animal healthcare companies, has entered into a multi-year agreement to use the ANAQUA IP platform to manage its global portfolio of patents, inventions, trademarks, and awards.

Headquartered in France, Ceva has 12 research and development centers, 25 production sites and more than 5,000 employees across more than 100 countries worldwide. With a sizeable and growing portfolio of patents, trademarks, and inventions, Ceva was seeking to upgrade its IP management systems and bring all of its IP assets onto a single platform, thereby increasing efficiency, saving time and reducing costs.

“With Anaqua’s unified IP management software, Ceva will be able to better manage the innovation process and more easily track the status of their valuable IP assets worldwide,” said Bob Romeo, CEO of Anaqua.  “Ceva has a truly global network of R&D teams who work together to keep shifting the boundaries of science, and we are looking forward to supporting their IP and innovation.”

Anaqua’s software will manage all of Ceva’s IP assets through a sole system across the entire company.  It will substantially automate and streamline daily docketing operations and provide flexible, reliable and updated reporting tools for its IP decisions.